Copy
Cannabis vs. Opioids: A Closer Look
View this email in your browser
Can Medical Cannabis Reduce Opioid Use?
February 19, 2017
  • Preliminary research suggests that pain patients in medical cannabis states use 11% fewer opioids.
  • Average number of pain reliever doses in medical states was nearly 96,000 in non-medical cannabis states compared to 85,000 in medical states.
  • Nationwide, prescriptions of opioid pain relievers jumped 272% in 22 years, from 76 million in 1991 to 207 million in 2013.
  • The three most commonly prescribed pain medications covered through Medicare (i.e., OxyContin, Hydrocodone, Fentanyl) cost the government $1.96 billion.
  • If medical cannabis was available nationally, the decreased Medicare expenditures on those three drugs alone would result in $220 million in savings for American taxpayers.
Indispensable to Sophisticated Investors
Invaluable to Successful Operators

Gain access to the latest business intelligence and stay on top of the rapidly changing cannabis industry with The Cannabis Industry Annual Report: 2017 Marijuana Outlook.

See why cannabis investors, operators and researchers in more than 45 countries have turned to New Frontier Data for their Business Intelligence.

New Frontier Data, the authority in real-time business intelligence for the cannabis industry, explores all aspects of the U.S. legal marijuana market after the sweeping legalization results of the 2016 Election.

Learn what you need to know:

  • National and State-level Market Sizing & Revenue Projections
  • Federal & State Regulatory Policies
  • Product and Industry Trends
  • Developments in Public Markets
  • Medical Cannabis Research & Innovation
  • Potential Impact of New Administration
  • Expansion of Legalization into International Markets

And much, much, much more!

Place Order and Save $200 Today!
Read the full article here.
Washington is Overtaking Colorado in Cannabis Sales
Leafly

Read the full article here.
Colorado County Using $425K in Local Pot Taxes for College Scholarships
The Cannabist
 
Germs, Mold Found in Some Medical Marijuana
San Francisco Firing up a Marijuana Department
San Francisco Chronicle

Read the full article here.
Copyright © 2016 Frontier Financial Group, Inc, All rights reserved.

Our mailing address is:

HEADQUARTERS:
1990 M Street, NW, Suite 530
Washington, DC 20036

SALES & MARKETING HUB:
535 16th Street, Suite 620
Denver, CO 80202



Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list